AzTrials
AzTrials

SuicideNCT04230434

Implementability and Effectiveness of the Safety Planning Intervention for Suicidal Behavior

A study testing Safety Plan Intervention in people with Suicide and Suicide, Attempted, run by Instituto de Investigación Hospital Universitario La Paz at 1 site in Spain.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The Safety Plan Intervention (SPI) has demonstrated to reduce suicide reattempts and to increase the ambulatory follow-up in american war veterans. This study evaluates the implementability and effectiveness in a significantly different population in a real world setting. Read more about this study

Who is it for?
Ages 18 to 100 years
Conditions the study is for
Suicide, Suicide, Attempted, Suicidal Ideation
What is being tested?
Safety Plan Intervention
Could I receive a placebo?
No, everyone receives an active treatment
How many people
58 participants
Where
1 siteSpain
Study dates
1 Aug 2019to 1 Feb 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 100 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Suicide attempt or presence of severe suicidal ideation
  • Signed Informed Consent Form

Who cannot join

  • Less than 18 years old
  • Hospitalization in the Psychiatry Department
  • Inability to understand the Safety Planning Intervention
  • Withdrawal criteria:
  • 1) Participant's decision to withdraw from the trial

Trial locations and contacts

1 site in 1 country.

Spain1 site
  • La Paz University Hospital

    Madrid, Madrid, 28029

Other trials in Spain

About this study

Official title: Safety-Planning Intervention for Suicidal Behavior in an Emergency Department: an Effectiveness-implementation Hybrid Design

The Safety Plan Intervention (SPI) has demonstrated to reduce suicide reattempts and to increase the ambulatory follow-up in american war veterans. This study evaluates the implementability and effectiveness in a significantly different population in a real world setting.

Read the detailed description

We will perform a Effectiveness-implementation Hybrid Design (Curran et al. 2012) to study firstly the feasibility of implementing the SPI in our clinical setting and secondly its effectiveness. The experimental arm will consist in a group of patients who visit the ED for a suicide-related concern in which the SPI is performed. This will be in the Emergency Department , unless for clinical reasons, the ED psychiatrist decide to postpone it to the first psychiatric appointment (which will be before one week of the ED visit as part of the treatment as usual).

Right after the SPI is performed, both the patient and the clinician will complete questionnaire with satisfaction and acceptability measures. Subjects will be followed for 6 months. At this time medical records will be consulted to obtain suicide reattempts rates and follow-up adherence.

At all times, the anonymity of the participants will be preserved and will require heading of informed consent, as well as other ethical aspects indicated by the Ethics Committee.

Being tested
Safety Plan Intervention
Keywords
Suicide, Suicidal behavior, Suicidal attempt, Suicide prevention, Safety Planning Intervention
Medical subject headings
Suicide, Suicide, Attempted, Suicidal Ideation, Suicide Prevention

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Safety Plan InterventionBehavioural

    Also called Security Plan

    The SPI has 6 key steps: (1) identify personalized warning signs for an impending suicide crisis; (2) determine internal coping strategies that distract from suicidal thoughts and urges; (3) identify family and friends who are able to distract from suicidal thoughts and urges and social places that provide the opportunity for interaction; (4) identify individuals who can help provide support during a suicidal crisis; (5) list mental health professionals and urgent care services to contact during a suicidal crisis; and (6) lethal means counseling for making the environment safer (Stanley \& Brown, 2012)

Study groups in NCT04230434
Study groupRoleWhat they receive
Safety Plan InterventionExperimentalThe Safety Plan Intervention (SPI) performed in ED or in ambulatory appointment
Receives: Behavioral: Safety Plan Intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Feasibility of Safety Plan Implementation

    Percentage of SPIs performed in ED from total number of suicide related ED visits.

    Measured: Baseline

Secondary outcomes (6)
  1. Time required for the performance of the SPI

    Minutes required for the performance of the SPI

    Measured: Baseline

  2. Satisfaction of the patient with the Safety Plan

    Likert-type scales with 5 levels of response will be measured through questions: "To what extent do the Safety Plan can help you to avoid a new situation of suicidal risk?"

    Measured: t0 (Safety Plan Performance )

  3. Satisfaction of the Professional with the Safety Plan

    Likert-type with 5 levels of response will be measured through questions: "To what extent do the Safety Plan can help you to avoid a new situation of suicidal risk?" Likert-type with 5 levels of response will be measured through questions: "To what extent the Safety Plan did you useful for the patient?". Open questions can be explained where contributions and obstacles encountered in its implementation will also be formulated.

    Measured: Baseline

  4. Presence of suicide reattempt

    Percentage of patients that commit suicide reattempt.

    Measured: Month 6

  5. Time to suicide reattempt

    Days from suicide attempt attended in the ED to the next suicide reattempt.

    Measured: Month 6

  6. Adherence to psychiatric ambulatory follow-up

    Percentage of patients that attend psychiatric ambulatory follow-up after ED discharge

    Measured: Month 6

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Jan 2020
  2. Study start1 Aug 2019
  3. Primary completion1 Jan 2020
  4. Study completion1 Feb 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Model description
Interventional cohort (Safety Plan Intervention)
Masking
None (open label)
Enrolment
58 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04230434
Sponsor's protocol ID
SPI-EI
Status last verified
Sep 2025
First submitted
29 Nov 2019
Last updated
11 Sep 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Data will be shared with other researchers on request

Questions about this trial

What is this clinical trial studying?

A study testing Safety Plan Intervention in people with Suicide and Suicide, Attempted, run by Instituto de Investigación Hospital Universitario La Paz at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 11 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Feasibility of Safety Plan Implementation (time frame: Baseline). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Sep 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in